| |
Dialysis
|
Control
|
|---|
| |
Endogenous (N = 25)
|
Exogenous (N = 7)
|
Endogenous (N = 31)
|
Exogenous (N = 26)
|
|---|
|
Clinical & laboratory
|
|
Days from symptom onset to ophthalmologists’ visit
|
1–30 (Median: 2 days)
|
1–7 (Median: 2 days)
|
1–30 (Median: 3 days)
|
1–30 (Median: 3 days)
|
|
Recent trauma or surgery
|
0
|
0%
|
7
|
100.0%
|
0
|
0%
|
26
|
100.0%
|
|
Days post eye surgery
| | |
3–20 (Median: 4 days)
| | |
1–35 (Median: 4 days)
|
|
Blurred vision
|
14
|
56%
|
2
|
28.5%
|
26
|
83.9%
|
25
|
96.2%
|
|
Ophthalmalgia
|
25
|
100%#
|
7
|
100%*
|
22
|
71.0%
|
20
|
76.9%
|
|
Peri-ocular swelling
|
25
|
100%#
|
6
|
85.7%*
|
10
|
32.2%
|
2
|
7.6%
|
|
Fever
|
8
|
32.0%
|
0
|
0%
|
17
|
54.8%
|
0
|
0%
|
|
Septic shock
|
2
|
8.0%
|
0
|
0%
|
5
|
16.1%
|
0
|
0%
|
|
Respiratory failure
|
2
|
8.0%
|
0
|
0%
|
1
|
3.2%
|
0
|
0%
|
|
Dialysis access infection
|
4
|
14.8%
|
0
|
0%
|
0
|
0%
|
0
|
0%
|
|
Leukocytosis
|
11
|
± 5
|
10
|
± 6
|
10
|
± 4
|
11
|
± 5
|
|
Serum CRP level
|
71
|
± 75
|
16
|
± 10
|
133
|
± 105
|
43
|
± 56
|
|
Microbiology
|
|
Bacteremia
|
8
|
32.0%
|
0
|
0%
|
13
|
41.9%
|
0
|
0%
|
|
Fungemia
|
0
|
0
|
0
|
0%
|
0
|
0%
|
0
|
0%
|
|
Positive vitreous culture
|
13
|
52.0%
|
4
|
57.1%
|
18
|
58.1%
|
19
|
73.1%
|
|
Treatment
|
|
IVI
|
12
|
48.0%+
|
7
|
100%
|
29
|
93.5%
|
25
|
96.2%
|
|
TPPV
|
2
|
8.0%
|
3
|
42.9%
|
2
|
6.5%
|
10
|
38.5%
|
|
Enucleation
|
5
|
20.0%
|
0
|
0%
|
6
|
19.4%
|
1
|
3.8%
|
|
Parenteral antibiotic only
|
8
|
32.0%
|
0
|
0%
|
0
|
0%
|
0
|
0%
|
-
CRP C-Reactive protein, IVI intra-vitreous injection, TPPV trans pars plana vitrectomy
-
#
p < 0.05 Endogenous: Dialysis v.s. Control
- *p < 0.05 Exogenous: Dialysis v.s. Control
-
+
p < 0.05 Endogenous: Dialysis v.s. Control
